Interactions of moxalactam and tobramycin in normal volunteers and in patients with impaired renal function.
In studies of the in vivo and in vitro interactions of moxalactam and tobramycin, normal volunteers and anuric patients were given one of the drugs or both drugs simultaneously, and the antibiotics were incubated separately or in combination in pooled human plasma. In both normal volunteers and patients with renal failure, the rate of elimination of tobramycin increased when the drug was given in combination with moxalactam. In patients with normal renal function, the rate of elimination of moxalactam decreased when the drug was given in combination with tobramycin; in contrast, this value did not decrease when the combination was given to anuric patients. In vitro, neither drug was affected by the presence of the other. Thus, the observed changes in elimination rates apparently are not caused by a chemical interaction that can be demonstrated in vitro. However, they are of sufficient magnitude to be of potential clinical significance.
D001002:Anuria / Q000097:blood / Q000378:metabolism*; D004347:Drug Interactions; D006801:Humans; D007700:Kinetics; D008297:Male; D009070:Moxalactam / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology; D014031:Tobramycin / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology
D009070:Moxalactam; D014031:Tobramycin